Integrated multi-omics reveals dysbiosis in hemodialysis patients: A multi-center study
PLOS One · 13.08.2026 · 21 (8) · e0355698
DOI: 10.1371/journal.pone.0355698 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 13.08.2026. Verfasst von Xinyue Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Renal Dialysis. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Hebei Province.
Abstract (Originalsprache)
Introduction
The gut microbiome-metabolome interplay in hemodialysis (HD) patients remains poorly characterized. Using multi-omics approaches, we compared HD patients with healthy controls (HC) to identify microbial signatures, metabolic perturbations, and their integrated correlations.
Methods
This case-control study included 192 participants (96 HD-HC pairs under identical dietary and living conditions). The gut microbiota composition was analyzed using 16S ribosomal RNA gene sequencing, and fecal metabolomes were analyzed using ultra-high-performance liquid chromatography and high-resolution mass spectrometry (UPLC-HRMS). A multi-omics analysis was conducted utilizing Spearman correlation analysis, Mantel test analysis, and differential functional pathway analysis.
Results
We observed significant differences in gut microbiota composition between the HD and HC groups, such as Ruminococcus and Bifidobacterium . Comparative analysis revealed 497 significantly altered metabolites in the HD group versus HC, primarily associated with amino acid, vitamin, lipid, purine, and pyrimidine metabolisms. ROC analysis identified 4-pyridoxic acid, nudifloramide, imidazoleacetic acid, ascorbic acid, and tocopheronic acid as potential diagnostic biomarkers (AUC > 0.8, p < 0.01). Integrated multi-omics analysis revealed correlations between Ruminococcus and metabolites such as Docosapentoic acid (DPA), 13 − EPAHAAB (EPA), and tryptamine, with shared differential pathways in bile secretion, caffeine metabolism, gastric acid secretion, and vitamin B6 metabolism.
Conclusion
Hemodialysis patients exhibited significant alterations in gut microbiota composition and metabolic profiles (amino acid, vitamin, and lipid metabolism) compared with healthy controls, with demonstrated microbiome-metabolome interactions and shared functional pathways. The potential diagnostic and therapeutic value of these differential features warrants further exploration and external validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Public Health, Hebei Medical University, Shijiazhuang, China.
- Department of Clinical Nutrition, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Clinical Nutrition, Xingtai People 's Hospital, Xingtai, China.
- Department of Clinical Nutrition, Dingzhou People 's Hospital, Dingzhou, China.
- Department of Clinical Nutrition, Harrison International Peace Hospital, Hengshui, China.
ORCID-Profile: Hailing Di
Förderung
- Health Commission of Hebei Province
Zitieren
APA
Zhang, X., Yu, D., Cui, Y., Chi, Y., Yan, Z., Song, Y., Hou, L., Qin, J., Zhang, J., Wang, Y., Wei, W., & Di, H. (2026). Integrated multi-omics reveals dysbiosis in hemodialysis patients: A multi-center study. PLOS One, 21(8), e0355698. https://doi.org/10.1371/journal.pone.0355698
Vancouver
Zhang X, Yu D, Cui Y, Chi Y, Yan Z, Song Y, et al. Integrated multi-omics reveals dysbiosis in hemodialysis patients: A multi-center study. PLOS One. 2026;21(8):e0355698. doi:10.1371/journal.pone.0355698
BibTeX
@article{Zhang2026,
author = {Zhang, Xinyue and Yu, Dan and Cui, Yupeng and Chi, Yanqing and Yan, Zhenyu and Song, Yang and Hou, Liping and Qin, Jin and Zhang, Jingjing and Wang, Yuanyuan and Wei, Wei and Di, Hailing},
title = {Integrated multi-omics reveals dysbiosis in hemodialysis patients: A multi-center study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0355698},
doi = {10.1371/journal.pone.0355698}
}
EUVIMED